Emrelis (telisotuzumab vedotin-tllv) has been granted accelerated approval by the US Food and Drug Administration (FDA), said ...

London-based specialty pharmaceutical company CNX Therapeutics is set to fast-track its European growth strategy after being ...

German science and technology company Merck (MRK: DE) reported a solid start to 2025, with group net sales rising 2.5% ...

German pharmaceutical company Boehringer Ingelheim has entered a multi-year collaboration with Tempus AI (Nasdaq: TEM), ...

Aiming to expand its hepatology portfolio, UK pharma major GSK (LSE: GSK) yesterday announced that it has entered into an ...

US Department of Health and Human Services (HHS) Secretary Robert F Kennedy Jr (RFK Jr) has spoken in defence of his proposed ...

Marking the latest move to pledge to spend billions of dollars into the USA, French pharm major Sanofi (Euronext: SAN) ...

Danish dermatology specialist LEO Pharma today released financial results for the first-quarter of 2025, noting its continued ...

Japanese pharma major Takeda (TYO: 4502) announced that the US Food and Drug Administration (FDA) has accepted for priority ...

Japanese drugmaker Chugai Pharmaceutical (TYO: 4519) has obtained regulatory approval from the domestic regulator for ...

The US Food and Drug Administration approved Welireg (belzutifan), from US pharma giant Merck & Co (NYSE: MRK), for adult and ...

A clinical-stage biotech company developing targeted therapeutics for rare neurodevelopmental disorders. The company’s lead ...